ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted.

June 20, 2003

Professional Societies: ONS To Study Trends In Health Economics Affecting Nursing

October 4, 1996

Combination Skin Treatments Reduce Rash From Vectibix

June 26, 2009

Highlights of Dingell Hearing: Statements Of Visco, Testimony By Broder On Fisher, Uterine Cancer Deaths

April 22, 1994

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003